Seeking Alpha

Perrigo (PRGO) is up 1.7% after announcing it has filed for a new drug application with the FDA...

Perrigo (PRGO) is up 1.7% after announcing it has filed for a new drug application with the FDA for its Androgel testosterone gel, which currently generates $900M in annual worldwide sales. However, Perrigo adds that Abbott (ABT) has filed a patent infringement suit against it over the product.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|